Yolanda Smith

Feature Writer

B.Pharm.

Pharmacy

Yolanda graduated with a Bachelor of Pharmacy at the University of South Australia and has experience working in both Australia and Italy. She is passionate about how medicine, diet and lifestyle affect our health and enjoys helping people understand this. In her spare time she loves to explore the world and learn about new cultures and languages.

Articles from Yolanda

Thalassemia Genetic Prevalence

Thalassemia is a genetic disorder that is due to mutations of the genes that are responsible for the production of hemoglobin in the blood.

23 Nov 2009

Thalassemia Prevalence

Thalassemia affects approximately 4.4 of every 10,000 live births throughout the world.

23 Nov 2009

Thalassemia Pathophysiology

Thalassemia is a blood disorder that is caused by DNA mutations in cells that are responsible for producing hemoglobin. Read more here.

23 Nov 2009

Tay-Sachs Disease Research

There remains a significant need for research into therapeutic approaches that could be useful in the treatment of Tay-Sachs disease.

23 Nov 2009

Tay-Sachs Disease Society and Culture

Tay-Sachs disease is a genetic disease that has been at the forefront of scientific research on inheritance patterns.

23 Nov 2009

Tay-Sachs Disease Prevention

Tay-Sachs is a genetic disease that can be prevented through certain methods of mate selection, antenatal screening, and preimplantation genetic diagnosis.

23 Nov 2009

Tay-Sachs Disease Diagnosis

The diagnosis of Tay-Sachs disease involves a consultation to gather details about the family and medical history of the patient, followed by a physical examination and blood tests to confirm the diagnosis.

23 Nov 2009

Tay-Sachs Disease Pathophysiology

Tay-Sachs Disease is a progressive and fatal genetic condition that involves a complete deficiency of the hexosaminidase-A (HEXA) enzyme. This enzyme is needed in healthy individuals for the process of hydrolysis of GM2 ganglioside to occur. For individuals with Tay-Sachs disease that lack this enzyme, the fatty substance of GM2 ganglioside accumulates in the brain and leads to the symptoms of the disease.

23 Nov 2009